Prelude Therapeutics Stock (PRLD)
Track Prelude Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
PRLD
Prelude Therapeutics
healthcare
$4.06
▲ +3.36 (+420.00%) past year
Market Cap
$325.75M
P/E Ratio
—
1Y Return
+420.00%
EPS (TTM)
-$1.06
Read the latest TheStreet Pro articles mentioning Prelude Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning PRLD yet.
Daily Diary Mentions
0 mentionsNo diary mentions for PRLD yet.